Cargando…

A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria

BACKGROUND: Tafenoquine is an investigational 8-aminoquinoline for the prevention of Plasmodium vivax relapse. Tafenoquine has a long half-life and the potential for more convenient dosing, compared with the currently recommended 14-day primaquine regimen. METHODS: This randomized, active-control, d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukuda, Mark M., Krudsood, Srivicha, Mohamed, Khadeeja, Green, Justin A., Warrasak, Sukhuma, Noedl, Harald, Euswas, Ataya, Ittiverakul, Mali, Buathong, Nillawan, Sriwichai, Sabaithip, Miller, R. Scott, Ohrt, Colin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679603/ https://www.ncbi.nlm.nih.gov/pubmed/29121061 http://dx.doi.org/10.1371/journal.pone.0187376

Ejemplares similares

Definite Ocular Sarcoidosis Using Endobronchial Ultrasonography with Transbronchial Needle Aspiration
por: Warrasak, Sukhuma, et al.
Publicado: (2014)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
por: St Jean, Pamela L., et al.
Publicado: (2020)

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
por: Lacerda, M.V.G., et al.
Publicado: (2019)

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping
por: Beck, Hans-Peter, et al.
Publicado: (2016)

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015)

Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment
por: Lin, Jessica T., et al.
Publicado: (2011)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Tafenoquine for Plasmodium vivax malaria: Concerns regarding efficacy & safety
por: Sharma, Jatin, et al.
Publicado: (2021)

Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial
por: St Jean, Pamela L., et al.
Publicado: (2016)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
por: Duparc, Stephan, et al.
Publicado: (2020)

Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
por: Suh, Jiyeon, et al.
Publicado: (2022)

Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay
por: Tyner, Stuart D, et al.
Publicado: (2012)

Severe orthostatic hypotension in otherwise uncomplicated Plasmodium vivax infection
por: Sivakorn, Chaisith, et al.
Publicado: (2021)

Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine
por: Lon, Chanthap, et al.
Publicado: (2014)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
por: Ebstie, Yehenew A, et al.
Publicado: (2016)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021)

Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study
por: Nekkab, Narimane, et al.
Publicado: (2021)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
por: Markus, Miles B
Publicado: (2021)

Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes
por: Maneerattanasak, Sarunya, et al.
Publicado: (2017)

Genetic diversity among Plasmodium vivax isolates along the Thai–Myanmar border of Thailand
por: Maneerattanasak, Sarunya, et al.
Publicado: (2016)

Suppression of Plasmodium falciparum by serum collected from a case of Plasmodium vivax infection
por: Nagao, Yoshiro, et al.
Publicado: (2008)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
por: Watson, James A, et al.
Publicado: (2022)

Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set
por: Sharma, Raman, et al.
Publicado: (2023)

Co-Infection with Plasmodium vivax and COVID-19 in Thailand
por: Boonyarangka, Parat, et al.
Publicado: (2022)

Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria
por: Mayence, Annie, et al.
Publicado: (2019)

Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
por: Hounkpatin, Aurore B, et al.
Publicado: (2019)

Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)
por: Dow, Geoffrey S, et al.
Publicado: (2011)

Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia
por: Wojnarski, Bertha, et al.
Publicado: (2020)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

An Observational Study of the Effect of Hemoglobinopathy, Alpha Thalassemia and Hemoglobin E on P. Vivax Parasitemia
por: Para, Suparak, et al.
Publicado: (2018)

Evaluation of the NOW Malaria Immunochromatographic Test for Quantitative Diagnosis of Falciparum and Vivax Malaria Parasite Density
por: Katakai, Yuko, et al.
Publicado: (2011)

Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study
por: Sutanto, Inge, et al.
Publicado: (2023)

Performance of BinaxNOW G6PD Deficiency Point-of-Care Diagnostic in P. vivax-Infected Subjects
por: Osorio, Lyda, et al.
Publicado: (2015)

Genetic Polymorphisms in Plasmodium vivax Dihydrofolate Reductase and Dihydropteroate Synthase in Isolates from the Philippines, Bangladesh, and Nepal
por: Thongdee, Pimwan, et al.
Publicado: (2015)

Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia
por: Gosi, Panita, et al.
Publicado: (2013)

Imported Plasmodium falciparum and locally transmitted Plasmodium vivax: cross-border malaria transmission scenario in northwestern Thailand
por: Sriwichai, Patchara, et al.
Publicado: (2017)

Tafenoquine succinate for malaria prevention
Publicado: (2019)

Tafenoquine: a toxicity overview
por: Chu, Cindy S., et al.
Publicado: (2021)

Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects
por: Green, Justin A, et al.
Publicado: (2014)

Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects
por: Green, Justin A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7okcrqgfa6eljh8om169dnsemu